| Active substance |
Mometasone |
| Also known as |
Mometasone |
| Blood pressure |
Typically has no effect on blood pressure |
| Chemical name |
(11ОІ,16О±)-9,21-Dichloro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione |
| Dosage (medical) |
Typically 50 mcg per spray for nasal sprays, 0.1% cream or ointment applied once daily |
| Dosage (sports) |
Not applicable as not typically used in sports settings |
| Effects |
Reduces inflammation, decreases swelling and itching |
| Formula |
C27H30Cl2O6 |
| Half-life |
5.8 hours |
| Hepatotoxicity |
Low |
| Lab Test |
Not typically monitored by specific lab tests in clinical settings |
| Main action |
Anti-inflammatory |
| Side effects |
Nasal irritation and burning, headache, pharyngitis, increased risk of infection, potential systemic effects with long-term use |
| Storage conditions |
Store at controlled room temperature, away from light and moisture |
| Strength |
50mcg |
| Substance class |
Corticosteroid |
| Trade name |
Nasonex, Elocon |
| Use in sports |
Not commonly used, potential for misuse as anti-inflammatory |
| Water Retention |
Minimal |
| Manufacturer |
Cipla Ltd. |
| Packing |
1 bottle/pack |
